Diabetic peripheral neuropathy
Diabetic peripheral neuropathy is one of the most common chronic complications of diabetes. It is a group of peripheral neuropathies with sensory and autonomic nerve symptoms as the main clinical manifestations. It, together with diabetic nephropathy and diabetic retinopathy, constitutes the diabetic triad, which seriously affects the quality of life of diabetic patients.
-
Site of disease:
Peripheral nervous system Pancreas -
Infectious :
Not contagious -
Frequent population:
Diabetic patients -
Related symptoms:
Slow reaction nausea dizziness tremors decreased or absent superficial sensation -
Concurrent disease:
Related Drugs
Tangmaikang Granules
Manufacturer:
Chengdu Beite Denuo Pharmaceutical Co., Ltd.
DULOXETINE HYDROCHLORIDE DELAYED RELEASE- duloxetine hydrochloride_capsule, delayed release pellets
Indication: Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder [see Clinical Studies (14. 1) Generalized Anxiety Disorder [see Clinical Studies (14. 2) Diabetic Peripheral Neuropathy [see Clinical Studies (14. 3) Chronic Musculoskeletal Pain [see Clinical Studies (14. 5) Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) ( 1 Generalized Anxiety Disorder (GAD) ( 1 Diabetic Peripheral Neuropathic Pain (DPNP) ( 1 Chronic Musculoskeletal Pain ( 1.
Manufacturer:
Innovida Pharmaceutique Corporation
LYRICA- pregabalin_capsule
Indication: LYRICA is indicated for: LYRICA Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1. 1 Post herpetic neuralgia (PHN) ( 1. 2 Adjunctive therapy for adult patients with partial onset seizures ( 1. 3 Fibromyalgia ( 1.
Manufacturer:
Quality Care Products, LLC
DULOXETINE- duloxetine_capsule, delayed release
Indication: Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder [see Clinical Studies ( 14. 1 Generalized Anxiety Disorder [see Clinical Studies ( 14. 2 Diabetic Peripheral Neuropathy [see Clinical Studies ( 14. 3 Chronic Musculoskeletal Pain [see Clinical Studies ( 14. 5 Duloxetine Major Depressive Disorder (MDD) ( 1 Generalized Anxiety Disorder (GAD) ( 1 Diabetic Peripheral Neuropathic Pain (DPNP) ( 1 Chronic Musculoskeletal Pain ( 1.
Manufacturer:
Zydus Pharmaceuticals USA Inc.
DULOXETINE- duloxetine hydrochloride_capsule, delayed release
Indication: Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder [see Clinical Studies (14. 1) Generalized Anxiety Disorder [see Clinical Studies (14. 2) Diabetic Peripheral Neuropathy [see Clinical Studies (14. 3) Chronic Musculoskeletal Pain [see Clinical Studies (14. 5) Duloxetine delayed-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) ( 1 Generalized Anxiety Disorder (GAD) ( 1 Diabetic Peripheral Neuropathic Pain (DPNP) ( 1 Chronic Musculoskeletal Pain ( 1.
Manufacturer:
REMEDYREPACK INC.